Patients News | pharmaphorum

News

Cala launches wearable to treat hand tremor in Parkinson's

US bioelectronics company Cala has formally launched its wristwatch-like Cala kIQ device to relieve hand tremors in people with Parkinson’s disease, adding to its current

News

Capreolos debuts ‘prehab’ app for people facing surgery

Faced with the prospect of needing major surgery, most people will be anxious and desperate for information, but often don’t ask the right questions of their doctors, says

News

Trial of 2seventy bio’s AML cell therapy paused after fatali...

Shares in 2seventy bio were on the slide this morning after the US biotech said Seattle Children’s Therapeutics had paused a clinical trial of its T-cell therapy for acute

News

In-ear wearable start-up STAT has long COVID in its sights

A new US start-up, STAT Health, has emerged from the shadows with $5.1 million in funding to develop an in-ear wearable

News

Futura gets FDA nod for OTC erectile dysfunction therapy

Futura Medical has become the first company in the US to bring a topical erectile dysfunction therapy to market that does not require a prescription.

News

Huma CEO Dan Vahdat speaking at World Economic Forum in Davos, 2023

Class II approval revs up Huma’s SaMD platform

Huma Therapeutics has been granted Class II clearance from the FDA for its Software-as-a-Medical-Device (SaMD) disease management platform, dramatically expanding the rang

Cala launches wearable to treat hand tremor in Parkinson's

Capreolos debuts ‘prehab’ app for people facing surgery

Trial of 2seventy bio’s AML cell therapy paused after fatali...

In-ear wearable start-up STAT has long COVID in its sights

Futura gets FDA nod for OTC erectile dysfunction therapy

Class II approval revs up Huma’s SaMD platform

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks